Abstract
Background Long-term fasting is a promising strategy for improving human health and reducing cardiometabolic risk. Emerging evidence suggests that the gut microbiome may mediate many of these benefits, but the role of its viral component, dominated by bacteriophages, remains poorly understood.
Methods Using shotgun metagenomic data from a single-arm, monocentric fasting intervention, this study profiled the gut virome (n=89 individuals, n=241 samples) before and after 9.8 days of fasting (∼250 kcal/day) as well as one and three months afterwards to examine viral population dynamics and their role in microbiome restructuring and host health.
Results Fasting induced a transient loss of viral diversity and a shift toward virulent lifestyles consistent with prophage induction. External dataset validation identified 49 phages that were reproducibly differentially abundant at the end of the fast. Many were linked to bacterial hosts, showing concordant shifts, including depletion of Faecalibacterium-associated phages and enrichment of Bacteroides-associated phages. Cross-domain network analyses revealed denser, more cohesive viral-bacterial networks at the end of fast, with enriched connections to key butyrate producers, such as Faecalibacterium and Roseburia species, suggesting phages reinforce health-associated taxa as ecological anchors during fasting-induced restructuring. Fasting-induced microbiome restructuring is distinct from inflammatory disease-associated patterns.
Conclusion Collectively, these findings indicate that fasting remodels cross-domain associations through reproducible, functionally relevant phage-host interactions, with reorganisation persisting for up to three months and aligning with improvements in cardiometabolic health. More broadly, these findings position the gut virome as a dynamic and structured component of dietary responsiveness, hinting that phage-host systems may play an underappreciated role in coordinating adaptive microbiome responses to metabolic interventions.
Competing Interest Statement
Authors FG and RM are employees of the Buchinger Wilhelmi Development and Holding GmbH. The author declares that they have no competing interests.
Clinical Trial
NCT05449249 and NCT05031598
Funding Statement
The data analysed in this retrospective project were originally generated in a study funded by Buchinger Wilhelmi Development & Holding GmbH. The author has no financial relationship beyond academic collaboration. This project was conducted as part of the requirements for the MSc in Human Nutrition at St Marys University, Twickenham, and received no external funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Metagenomic sequencing datasets and accompanying clinical data from two previously reported fasting cohorts at the Buchinger Wilhelmi Clinic (BWC), Ueberlingen, Germany, were re-analysed for this study: OralFast (NCT05449249) and GENESIS (NCT05031598). Ethics committee from the State Medical Association of Baden-Wuerttemberg gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data availability
Raw metagenomic sequencing data analysed in this study are available through the European Nucleotide Archive under the following accession numbers: PRJEB74035 (discovery cohort), PRJNA698459 (Maifeld et al.), and PRJEB75353 (Grundler et al.).
